Microarray profiling of multiple myeloma plasma cells and drug resistant glioblastomas has also detected underexpression of RGC-32 mRNA [35]–[36] implicating downregulation of RGC-32 in tumour development/progression. The gene discussed is RGCC; the disease is neoplasm.